col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


23 Ergebisse       Seite 1

 [1] 
American Society for Pharmacology & Experimental Therapeutics: Journal of Pharmacology and Experimental Therapeutics
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Mrz―29 Kruppel-like Factor 2 (KLF2) Reduces Parameters of Coronavirus Disease-Related Pathogenesis (Abstract ID: 158457) MD Sariful Islam Howlader, Manjusri Das, Surajit Hansda, Prathyusha Naidu, Hiranmoy Das
2 [GO] 2025―Mrz―28 SARS-CoV-2 Propagation Relies on Host Chaperonin CCT/TRiC Folding of Viral Polymerase Nsp12 (Abstract ID: 171782) Cecilia S. Sanders, Theresa M. Smith, Caelen A. Jones, Gavin T. Scholl, Mikaila Sass, Peter Shen, Barry Willardson
3 [GO] 2025―Mrz―28 Targeting S1PR1 for Post-Acute Neurocognitive Sequalae of SARS-CoV-2 (Abstract ID: 163823) Susan Farr, Heather Macarathur, Ivonne G. Larrea, Timothy Doyle, Daniela Salvemini
4 [GO] 2024―Aug―23 KVX-053, a Protein Tyrosine Phosphatase 4A3 inhibitor, ameliorates SARS-CoV-2 Spike protein subunit 1 - induced acute lung injury in mice Pavel A Solopov, Ruben Manuel Luciano Colunga Biancatelli, Tierney Day, Betsy Gregory, Elizabeth R Sharlow, John S. Lazo, John D Catravas
5 [GO] 2024―Feb―09 Endothelial extracellular vesicles enriched in microRNA-34a predict new-onset diabetes in COVID-19 patients: novel insights for long-COVID metabolic sequelae Pasquale Mone, Stanislovas S. Jankauskas, Maria Virginia Manzi, Jessica Gambardella, Antonietta Coppola, Urna Kansakar, et al. (+7)
6 [GO] 2023―Mai―18 Finasteride Induces Epigenetic Alteration of TMPRss2 Gene Expression: A Potential role in Severe Acute Respiratory Syndrome-Corona Virus-2 Inhibition Churchill Ihentuge, Antonei B. Csoka
7 [GO] 2023―Mai―18 Molecular Dynamics Studies for Nirmatrelvir and the Main Protease from Variants of the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Kathleen Frey, Ongshu Dutta, Lilian Tran, Brandon Yin, Andrew Makarus, Raymond Marmol, Youssef Dawood
8 [GO] 2023―Mai―18 Characterization of the pharmacological mechanism of OJT009 as a novel inhibitor of severe acute respiratory syndrome coronavirus 2 Tolulope Adebusuyi, Manvir Kaur, Anuoluwapo O. Egbejimi, Idowu Kehinde, Omonike A. Olaeye
9 [GO] 2023―Mai―18 Changes of ACE-2 related-miR-200b-3p expression over time are a predictive factor of long hospitalization for COVID-19: in silico, machine learning and validation analysis Disha Keswani, Mikolaj Marszalek, Zofia Wicik, Ceren Eyileten, Anna Nowak, Sérgio Simões, et al. (+8)
10 [GO] 2023―Mai―18 Pharmacovigilance of the COVID-19 Vaccine in Ecuador During the First and Second Doses of Vaccination Campaigns Andrea Orellana Manzano, Fernanda B. Cordeiro, Andrea Garcia-Angulo, Diana Carvajal-Aldaz, Elizabeth Centeno, Maria J. Vizcaíno, et al. (+5)
11 [GO] 2023―Mai―18 Development of Humanized ACE2 Mouse and Rat Models for COVID-19 Research Hongmei Jiang, Emma Hyddmark, Jianqiu Xiao, Sara Gordon, Angela Bartels, Yumei Wu, et al. (+6)
12 [GO] 2023―Mai―18 Renin-Angiotensin System Components and Arachidonic Acid Metabolites as Biomarkers of COVID-19 Biwash Ghimire, Sana Khajehpour, Nasser Jalili Jahani, Elizabeth A. Middleton, Robert Campbell, Mary Nies, Ali Aghazadeh-Habashi
13 [GO] 2023―Apr―27 Modulation of the immune response to SARS-CoV-2 vaccination by NSAIDs Carsten Skarke, Ronan Lordan, Kayla Barekat, Amruta Naik, Divij Mathew, Takuya Ohtani, et al. (+13)
14 [GO] 2022―Jul―03 Cardiovascular implications of miRNAs in COVID-19 Carmine Izzo, Valeria Visco, Jessica Gambardella, Germano Junior Ferruzzi, Antonella Rispoli, Maria Rosaria Rusciano, et al. (+7)
15 [GO] 2022―Jun―30 Exosomal miR-145 and miR-885 regulate thrombosis in COVID-19 Jessica Gambardella, Urna Kansakar, Celestino Sardu, Vincenzo Messina, Stanislovas S. Jankauskas, Raffaele Marfella, et al. (+6)
16 [GO] 2022―Mrz―26 L-Arginine Enhances the Effects of Cardiac Rehabilitation on Physical Performance: New Insights for Managing Cardiovascular Patients During the COVID-19 Pandemic Pasquale Mone, Raffaele Izzo, Giuseppe Marazzi, Maria Virginia Manzi, Paola Gallo, Giuseppe Campolongo, et al. (+6)
17 [GO] 2021―Jul―12 Cationic Compounds with SARS-CoV-2 Antiviral Activity and their Interaction with OCT/MATE Secretory Transporters. Lucy Jazmin Martinez Guerrero, Xiaohong Zhang, Kimberley M. Zorn, Sean Ekins, Stephen H. Wright
18 [GO] 2021―Mai―10 Viral Proteases as Targets for COVID-19 Drug Development Wei Zhu, Zeenat A Shyr, Donald C. Lo, Wei Zheng
19 [GO] 2021―Mrz―05 COVID-19 drugs chloroquine and hydroxychloroquine, but not azithromycin and remdesivir, block hERG potassium channels Mark Szendrey, Jun Guo, Wentao Li, Tonghua Yang, Shetuan Zhang
20 [GO] 2020―Okt―28 A Biomarker-Centric Approach to Drug Discovery and Development: Lessons Learned from the COVID-19 Pandemic Kelly A. Fader, Jiangwei Zhang, Joseph P. Menetski, Ravi I. Thadhani, Elliott M. Antman, Gary S. Friedman, et al. (+2)
21 [GO] 2020―Okt―08 The Role of Smoking and Nicotine in the Transmission and Pathogenesis of COVID-19 Ali Ehsan Sifat, Saeideh Nozohouri, Heidi Villalba, Bhuvaneshwar Vaidya, Thomas J. Abbruscato
22 [GO] 2020―Okt―02 Role of GILZ in the Kidney and the Cardiovascular System: Relevance to Cardiorenal Complications of COVID-19 Mahmood Mozaffari
23 [GO] 2020―Jul―29 Drug discovery strategies for SARS-CoV-2 Zeenat A Shyr, Kirill Gorshkov, Catherine Z Chen, Wei Zheng
 [1] 

23 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec